Randomized trials neutral for pump device in complex elective cases, STEMI with reperfusio ...

An older man presents with acute coronary syndrome and a large atrial myxoma, complicating diagnosis and guiding decisions on revascularization and surgery.

Please provide your email address to receive an email when new articles are posted on . A guideline for managing patients with acute coronary syndrome was issued by several U.S. societies. The ...

PARIS — Adding the PCSK9 inhibitor evolocumab (Repatha, Amgen) to high-intensity statin therapy in the very high-risk setting of acute coronary syndrome (ACS) safely lowers low-density lipoprotein ...

Coronary artery disease (CAD) is the leading cause of death worldwide, with acute myocardial infarction (MI) representing the ...

Introduction Poor adherence to risk factor control and life-saving medications is a key factor affecting long-term patient ...

Amgen Canada announced today that the Governments of Ontario and Quebec have expanded public reimbursement of Repatha® (evolocumab injection) for eligible patients following an acute coronary syndrome ...

The European Society of Cardiology (ESC) Guidelines on acute coronary syndromes are published online today in European Heart Journal. The document covers the management of unstable angina and all ...

Two posters presented at the CHEST 2024 annual meeting highlighted significant disparities in acute coronary syndrome care and outcomes among different racial, ethnic, and gender groups, underscoring ...

Acute coronary syndrome (ACS) in younger patients presents distinctive epidemiological and clinical patterns when compared with older cohorts. Although traditionally viewed as a disease of older ...

Takotsubo syndrome (TTS) is an acute and reversible form of heart failure characterised by transient left ventricular (LV) ...